Rchr
J-GLOBAL ID：202201000471149439
Update date: Aug. 28, 2024
Fujiyama Nobuhiro
フジヤマ ノブヒロ | Fujiyama Nobuhiro
Affiliation and department：
Research field (2)：
Pharmacology
, Immunology
Research theme for competitive and other funds (5)：
- 2021 - 2025 免疫チェックポイント阻害薬の治療有効性・抵抗性の要因評価~宿主腫瘍HLA環境解析
- 2017 - 2023 KIRリガンドミスマッチによる腎移植後悪性腫瘍発症抑制効果の検討
- 2015 - 2018 Influence of tacrolimus initial doing strategy based on the CYP3A5 polymorphisms on quantitative interstitial fibrosis, rejection rate, and long-term graft function in kidney transplant recipients.
- 2015 - 2018 Establishment of novel therapeutic system for renal cell carcinoma by pahrmacogenomics and transcriptomics
- 2015 - 2017 Can anti-HLA antibody in sera of kidney transplant recipients be avoided by immunosuppressant control ?
Papers (24)：
-
Tokiyoshi Tanegashima, Masaki Shiota, Nobuhiro Fujiyama, Shintaro Narita, Tomonori Habuchi, Genshiro Fukuchi, Dai Takamatsu, Yoshinao Oda, Hideaki Miyake, Masayuki Takahashi, et al. Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study. Journal of immunology (Baltimore, Md. : 1950). 2024. 213. 1. 23-28
-
Nobuhiro Fujiyama, Masayuki Tasaki, Hiroshi Harada, Koichi Tsutahara, Akihiko Matsumoto, Yuji Kamijo, Mariko Toyoda, Daiki Iwami, Masashi Inui, Hiroki Shirakawa, et al. Immunological risk and complement genetic evaluations in early onset de novo thrombotic microangiopathy after living donor kidney transplantation: a Japanese multicenter registry. Clinical and experimental nephrology. 2023
-
Hiroshi Harada, Nobuyuki Fukuzawa, Toyofumi Abe, Ryoichi Imamura, Noriyuki Masaki, Nobuhiro Fujiyama, Shigeru Sato, Shingo Hatakeyama, Kenji Nishimura, Hidefumi Kishikawa, et al. Development and nationwide validation of kidney graft injury markers using urinary exosomes and microvesicles (complete English translation of the Japanese version). BMC Nephrology. 2023. 24. 1
-
Shuhei Takahashi, Shintaro Narita, Nobuhiro Fujiyama, Shingo Hatakeyama, Takashi Kobayashi, Renpei Kato, Sei Naito, Toru Sakatani, Soki Kashima, Atsushi Koizumi, et al. Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab. Cancer science. 2022. 113. 12. 4059-4069
-
Mizuki Kobayashi, Nobuhiro Fujiyama, Tokiyoshi Tanegashima, Shintaro Narita, Yoshiaki Yamamoto, Naohiro Fujimoto, Shohei Ueda, Ario Takeuchi, Kazuyuki Numakura, Tomonori Habuchi, et al. Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer. Cancer immunology, immunotherapy : CII. 2022. 71. 3. 727-736
ｍore...
MISC (4)：
-
Yu Ho Lee, Yuki Sato, Mitsuru Saito, Shingo Fukuma, Atsushi Komatsuda, Nobuhiro Fujiyama, Shigeru Satoh, Tomonori Habuchi, Sang-Ho Lee, Peter Peter, et al. ADVANCED TERTIARY LYMPHOID TISSUES IN PROTOCOL BIOPSIES PREDICT PROGRESSIVE GRAFT DYSFUNCTION IN KIDNEY TRANSPLANT RECIPIENTS. TRANSPLANTATION. 2020. 104. 9. S39-S39
-
Ryoma Igarashi, Norihiko Tsuchiya, Takamitsu Inoue, Nobuhiro Fujiyama, Kazuyuki Numakura, Hiroshi Tsuruta, Hideaki Kagaya, Atsushi Maeno, Mitsuru Saito, Shintaro Narita, et al. CONTRIBUTION OF GENETIC POLYMORPHISMS RELATED TO AXITINIB PHARMACOKINETICS TO THE CLINICAL SAFETY AND EFFICACY IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA. JOURNAL OF UROLOGY. 2017. 197. 4. E182-E182
-
Norihiko Tsuchiya, Nobuhiro Fujiyama, Ryoma Igarashi, Naoko Honma, Shintaro Narita, Takamitsu Inoue, Kazuyuki Numakura, Susumu Akihama, Mitsuru Saito, Shigeru Satoh, et al. ASSOCIATION BETWEEN PLASMA CONCENTRATION OF AXITINIB AND TREATMENT OUTCOME IN ADVANCED RENAL CELL CARCINOMA PATIENTS. JOURNAL OF UROLOGY. 2015. 193. 4. E872-E873
-
Norihiko Tsuchiya, Ryoma Igarashi, Naoko Suzuki-Honma, Nobuhiro Fujiyama, Shintaro Narita, Takamitsu Inoue, Mitsuru Saito, Susumu Akihama, Hiroshi Tsuruta, Masatomo Miura, et al. Association of pharmacokinetics of axitinib with treatment outcome and adverse events in advanced renal cell carcinoma patients. JOURNAL OF CLINICAL ONCOLOGY. 2015. 33. 7
Professional career (1)：
- Pharmacist, Ph.D. (Chiba University)
Work history (5)：
- 2017/04 - 現在 Akita University Hospital
- 2016/04 - 現在 Akita University Hospital
- 2013/10 - 現在 Akita University Hospital
- 2010/04 - 現在 あきた治験ネットワーク 事務局
- 2007/04 - Akita University Hospital
Return to Previous Page
